- Home
- NVAX vs SDHC Comparison
NVAX vs SDHC Comparison
Compare NVAX & SDHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NVAX
- SDHC
- Stock Information
- Founded
- NVAX 1987
- SDHC 2008
- Country
- NVAX United States
- SDHC United States
- Employees
- NVAX N/A
- SDHC N/A
- Industry
- NVAX Biotechnology: Biological Products (No Diagnostic Substances)
- SDHC
- Sector
- NVAX Health Care
- SDHC
- Exchange
- NVAX Nasdaq
- SDHC Nasdaq
- Market Cap
- NVAX 1.3B
- SDHC 1.2B
- IPO Year
- NVAX 1995
- SDHC 2024
- Fundamental
- Price
- NVAX $6.00
- SDHC $18.88
- Analyst Decision
- NVAX Buy
- SDHC Hold
- Analyst Count
- NVAX 6
- SDHC 4
- Target Price
- NVAX $17.83
- SDHC $30.25
- AVG Volume (30 Days)
- NVAX 6.0M
- SDHC 65.6K
- Earning Date
- NVAX 05-09-2025
- SDHC 05-13-2025
- Dividend Yield
- NVAX N/A
- SDHC N/A
- EPS Growth
- NVAX N/A
- SDHC N/A
- EPS
- NVAX N/A
- SDHC 1.81
- Revenue
- NVAX $682,162,000.00
- SDHC $975,463,000.00
- Revenue This Year
- NVAX $1.07
- SDHC $6.82
- Revenue Next Year
- NVAX N/A
- SDHC $11.61
- P/E Ratio
- NVAX N/A
- SDHC $10.44
- Revenue Growth
- NVAX N/A
- SDHC 27.57
- 52 Week Low
- NVAX $3.81
- SDHC $17.03
- 52 Week High
- NVAX $23.86
- SDHC $39.50
- Technical
- Relative Strength Index (RSI)
- NVAX 41.41
- SDHC 45.19
- Support Level
- NVAX $5.01
- SDHC $17.87
- Resistance Level
- NVAX $6.58
- SDHC $20.33
- Average True Range (ATR)
- NVAX 0.65
- SDHC 1.20
- MACD
- NVAX 0.02
- SDHC 0.05
- Stochastic Oscillator
- NVAX 50.25
- SDHC 56.06
About NVAX Novavax Inc.
Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. It works together with its wholly owned Swedish subsidiary to produce vaccine candidates to respond to both known and emerging disease threats. The company believes its vaccine technology has the potential to be applied broadly to a wide variety of human infectious diseases. The company manages its business as one operating segment, the development and commercialization of vaccines. The company generates maximum revenue from the United States.
About SDHC Smith Douglas Homes Corp.
Smith Douglas Homes Corp is a company engaged in the design, construction, and sale of single-family homes in some of the highest growth and desirable markets in the Southeastern United States. The company has organized into five geographical segments so their reportable segments include Atlanta, Raleigh, Charlotte, Nashville, and Alabama which consists of both Birmingham and Huntsville.